Similarly to other flavonoids, apigenin has been reported to target and to inhibit STAT3 in several cancers [18, 19] sometimes concomitantly with the activation of p53 tumor suppressor functions [18], leading to reduction of cancer cell survival. The gene discussed is TP53; the disease is cancer.